Drugs / egg-based H5N8 influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07779408 | Aug 2026 → Feb 2028 expected | influenza | Sanofi | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | egg-based H5N8 influenza vaccine | “egg-based H5N8 Influenza Vaccine” NCT07779408 ↗ |
| Modality | Vaccine | “H5N8 Influenza Vaccine” NCT07779408 ↗ |
| Route | Intramuscular | “Participants receive 2 intramuscular injections” NCT07779408 ↗ |